| 1 |
Lee HS, Kim EN, Jeong GS. Oral administration of Helianthus annuus leaf extract ameliorates atopic dermatitis by modulation of T cell activity in vivo. Phytomedicine 2022;106:154443. [PMID: 36108372 DOI: 10.1016/j.phymed.2022.154443] [Reference Citation Analysis]
|
| 2 |
Kang YM, Kim HM, Lee H, Lee DS, An HJ. Anti-inflammatory effects of Eclipta prostrata Linné on house dust mite-induced atopic dermatitis in vivo and in vitro. J Ethnopharmacol 2022;292:115233. [PMID: 35346812 DOI: 10.1016/j.jep.2022.115233] [Reference Citation Analysis]
|
| 3 |
Xu YR, Lei CQ. TAK1-TABs Complex: A Central Signalosome in Inflammatory Responses. Front Immunol 2020;11:608976. [PMID: 33469458 DOI: 10.3389/fimmu.2020.608976] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 4 |
Micale L, Morlino S, Biagini T, Carbone A, Fusco C, Ritelli M, Giambra V, Zoppi N, Nardella G, Notarangelo A, Schirizzi A, Mazzoccoli G, Grammatico P, Wade EM, Mazza T, Colombi M, Castori M. Insights into the molecular pathogenesis of cardiospondylocarpofacial syndrome: MAP3K7 c.737-7A > G variant alters the TGFβ-mediated α-SMA cytoskeleton assembly and autophagy. Biochim Biophys Acta Mol Basis Dis 2020;1866:165742. [PMID: 32105826 DOI: 10.1016/j.bbadis.2020.165742] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 5 |
Pan Y, Hou X, Meng Q, Yang X, Shang L, Wei X, Hao W. The critical role for TAK1 in trichloroethylene-induced contact hypersensitivity in vivo and in CD4+ T cell function alteration by trichloroethylene and its metabolites in vitro. Toxicol Appl Pharmacol 2019;380:114705. [PMID: 31400415 DOI: 10.1016/j.taap.2019.114705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Konkel JE, Zhang D, Zanvit P, Chia C, Zangarle-murray T, Jin W, Wang S, Chen W. Transforming Growth Factor-β Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses. Immunity 2017;46:660-74. [DOI: 10.1016/j.immuni.2017.03.015] [Cited by in Crossref: 133] [Cited by in F6Publishing: 139] [Article Influence: 22.2] [Reference Citation Analysis]
|
| 7 |
Hirata Y, Takahashi M, Morishita T, Noguchi T, Matsuzawa A. Post-Translational Modifications of the TAK1-TAB Complex. Int J Mol Sci 2017;18:E205. [PMID: 28106845 DOI: 10.3390/ijms18010205] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 8 |
Yao P, Hongqian C, Qinghe M, Lanqin S, Jianjun J, Xiaohua Y, Xuetao W, Weidong H. Lack of TAK1 in dendritic cells inhibits the contact hypersensitivity response induced by trichloroethylene in local lymph node assay. Toxicology and Applied Pharmacology 2016;307:72-80. [DOI: 10.1016/j.taap.2016.07.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 9 |
Pan Y, Lei Z, Wei X, Hao W. TAK1 deficiency in dendritic cells inhibits adaptive immunity in SRBC-immunized C57BL/6 mice. FEBS Open Bio 2016;6:548-57. [PMID: 27419057 DOI: 10.1002/2211-5463.12062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 10 |
Verstrepen L, Beyaert R. Receptor proximal kinases in NF-κB signaling as potential therapeutic targets in cancer and inflammation. Biochem Pharmacol 2014;92:519-29. [PMID: 25449604 DOI: 10.1016/j.bcp.2014.10.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 11 |
Karmaus PW, Chi H. Genetic dissection of dendritic cell homeostasis and function: lessons from cell type-specific gene ablation. Cell Mol Life Sci 2014;71:1893-906. [PMID: 24366237 DOI: 10.1007/s00018-013-1534-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 12 |
Martin SF. Allergic contact dermatitis: xenoinflammation of the skin. Curr Opin Immunol. 2012;24:720-729. [PMID: 22980498 DOI: 10.1016/j.coi.2012.08.003] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 13 |
Sakurai H. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol Sci 2012;33:522-30. [PMID: 22795313 DOI: 10.1016/j.tips.2012.06.007] [Cited by in Crossref: 254] [Cited by in F6Publishing: 265] [Article Influence: 23.1] [Reference Citation Analysis]
|
| 14 |
Wang Y, Huang G, Vogel P, Neale G, Reizis B, Chi H. Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function. Proc Natl Acad Sci U S A 2012;109:E343-52. [PMID: 22308391 DOI: 10.1073/pnas.1115635109] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
|
